NRF2 is over-activated in lung cancer either through mutations of the NRF2 encoding gene, NFE2L2, or loss-of-function mutations of KEAP1, whose protein product ubiquitinates and degrades NRF2 [25, 28, 29]. The gene discussed is NFE2L2; the disease is lung cancer.